Integer HoldingsITGR
About: Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into two business segments based on the product type: medical and nonmedical. The medical segment uses the firm's technologies to produce components and finished medical devices, and it generates the vast majority of revenue. The company earns more than half of its revenue in the United States.
Employees: 10,500
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
73% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 30
68% more call options, than puts
Call options by funds: $1.77M | Put options by funds: $1.05M
12% more capital invested
Capital invested by funds: $4.56B [Q2] → $5.11B (+$543M) [Q3]
7% more funds holding
Funds holding: 311 [Q2] → 333 (+22) [Q3]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]
0.76% less ownership
Funds ownership: 117.88% [Q2] → 117.13% (-0.76%) [Q3]
4% less repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 115
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
7 analyst ratings
Citigroup Joanne Wuensch 55% 1-year accuracy 26 / 47 met price target | 8%upside $145 | Neutral Maintained | 11 Dec 2024 |
Truist Securities Richard Newitter 79% 1-year accuracy 33 / 42 met price target | 22%upside $163 | Buy Maintained | 11 Dec 2024 |
Wells Fargo Nathan Treybeck 60% 1-year accuracy 3 / 5 met price target | 20%upside $160 | Overweight Reinstated | 3 Dec 2024 |
Piper Sandler Matt O'Brien 57% 1-year accuracy 29 / 51 met price target | 5%upside $140 | Overweight Reiterated | 25 Oct 2024 |
Benchmark Robert Wasserman 55% 1-year accuracy 27 / 49 met price target | 5%upside $140 | Buy Reiterated | 25 Oct 2024 |
Financial journalist opinion
